HALOPERIDOL DECANOATE V FLUPHENAZINE DECANOATE AS MAINTENANCE THERAPY IN CHRONIC-SCHIZOPHRENIC INPATIENTS

被引:14
作者
MCKANE, JP [1 ]
ROBINSON, ADT [1 ]
WILES, DH [1 ]
MCCREADIE, RG [1 ]
STIRLING, GS [1 ]
机构
[1] CRICHTON ROYAL HOSP,DUMFRIES DG1 4TG,SCOTLAND
关键词
D O I
10.1192/bjp.151.3.333
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
引用
收藏
页码:333 / 336
页数:4
相关论文
共 18 条
[1]  
AYD FJ, 1980, HALOPERIDOL UPDATE 1
[2]  
BECHELLI LPC, 1985, CURR THER RES CLIN E, V37, P662
[3]  
CHOUINARD G, 1984, PSYCHOPHARMACOL BULL, V20, P108
[4]  
DAVIS JM, 1976, ARCH GEN PSYCHIAT, V33, P858
[5]   INTRAMUSCULAR HALOPERIDOL DECANOATE FOR NEUROLEPTIC MAINTENANCE THERAPY - EFFICACY, DOSAGE SCHEDULE AND PLASMA-LEVELS - AN OPEN MULTI-CENTER STUDY [J].
DEBERDT, R ;
ELENS, P ;
BERGHMANS, W ;
HEYKANTS, J ;
WOESTENBORGHS, R ;
DRIESENS, F ;
REYNTJENS, A ;
VANWIJNGAARDEN, I .
ACTA PSYCHIATRICA SCANDINAVICA, 1980, 62 (04) :356-363
[6]   DIAGNOSTIC CRITERIA FOR USE IN PSYCHIATRIC RESEARCH [J].
FEIGHNER, JP ;
WOODRUFF, RA ;
WINOKUR, G ;
MUNOZ, R ;
ROBINS, E ;
GUZE, SB .
ARCHIVES OF GENERAL PSYCHIATRY, 1972, 26 (01) :57-&
[7]  
Guy W., 1976, ECDCEU ASSESSMENT MA
[8]   DOUBLE-BLIND COMPARISON OF HALOPERIDOL DECANOATE AND FLUPHENAZINE DECANOATE EFFECTIVENESS, SIDE-EFFECTS, DOSAGE AND SERUM LEVELS DURING A 6 MONTHS TREATMENT FOR RELAPSE PREVENTION [J].
KISSLING, W ;
MOLLER, HJ ;
WALTER, K ;
WITTMANN, B ;
KRUEGER, R ;
TRENK, D .
PHARMACOPSYCHIATRY, 1985, 18 (03) :240-245
[9]   STANDARDIZED PSYCHIATRIC-ASSESSMENT SCALE FOR RATING CHRONIC PSYCHOTIC-PATIENTS [J].
KRAWIECKA, M ;
GOLDBERG, D ;
VAUGHAN, M .
ACTA PSYCHIATRICA SCANDINAVICA, 1977, 55 (04) :299-308
[10]   INTERACTION OF LIFE EVENTS AND RELATIVES EXPRESSED EMOTION IN SCHIZOPHRENIA AND DEPRESSIVE NEUROSIS [J].
LEFF, J ;
VAUGHN, C .
BRITISH JOURNAL OF PSYCHIATRY, 1980, 136 (FEB) :146-153